Mayo Clinic

With synthetic opioids lurking, DNA detector scores

By GREGORY ZELLER // With synthetic opioids increasingly implicated in the alarming number of drug-overdose deaths plaguing the nation, a stalwart Long Island biotech’s DNA-based tracking technology has received a major endorsement. The peer-reviewed scientific journal PLOS ONE has published a paper by Stony Brook-based Applied DNA Sciences on the molecular tagging of pharmaceuticals – a next-gen supply-chain authenticator that Applied DNA considers unforgeable, inescapable and particularly useful in a world where counterfeit drugs are…

Northwell, Mayo Clinic tackle painkiller epidemic

By GREGORY ZELLER // Northwell Health will join the Mayo Clinic and one of the nation’s largest medical schools on a three-year study targeting painkiller addictions. Citing “a growing epidemic of opioid abuse,” the New Hyde Park-based health system announced this week a $350,000 stipend over three years from the nonprofit Washington-based Patient Centered Outcome Research Institute to fund a collaborative study designed to track painkiller dependency among ER patients, and ultimately lower the risk….